Randomized, blind, placebo-controlled clinical trial on the clinical efficacy of oclacitinib, an oral janus kinase inhibitor, in a canine model of spontaneously occurring atopic dermatitis

被引：0
|
作者：
Marsella, R. [1 ]
机构：
[1] Univ Florida, Dermatol, Gainesville, FL USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2016年 / 136卷 / 08期
关键词：
D O I：
10.1016/j.jid.2016.05.030
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB780
引用
收藏
页码：B6 / B6
页数：1
相关论文
共 50 条
  • [1] A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis
    Cosgrove, Sallie B.
    Wren, Jody A.
    Cleaver, Dawn M.
    Walsh, Kelly F.
    Follis, Stacey I.
    King, Vickie I.
    Tena, Jezaniah-Kira S.
    Stegemann, Michael R.
    VETERINARY DERMATOLOGY, 2013, 24 (06) : 587 - +
  • [2] Efficacy of a probiotic supplement in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled clinical trial
    Michelotti, Angela
    Cestone, Enza
    De Ponti, Ileana
    Giardina, Silvana
    Pisati, Marta
    Sparta, Eleonora
    Tursi, Francesco
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (02) : 225 - 232
  • [3] Efficacy of a probiotic supplement in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled clinical trial
    Angela Michelotti
    Enza Cestone
    Ileana De Ponti
    Silvana Giardina
    Marta Pisati
    Eleonora Spartà
    Francesco Tursi
    European Journal of Dermatology, 2021, 31 : 225 - 232
  • [4] Randomized controlled trial of an oral Janus kinase/spleen tyrosine kinase inhibitor for atopic dermatitis
    不详
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (11) : 2251 - 2251
  • [5] Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis A Phase 2 Randomized Clinical Trial
    Gooderham, Melinda J.
    Forman, Seth B.
    Bissonnette, Robert
    Beebe, Jean S.
    Zhang, Weidong
    Banfield, Chris
    Zhu, Linda
    Papacharalambous, Jocelyne
    Vincent, Michael S.
    Peeva, Elena
    JAMA DERMATOLOGY, 2019, 155 (12) : 1371 - 1379
  • [6] POLYPODIUM LEUCOTOMOS EXTRACT IN ATOPIC DERMATITIS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND MULTICENTER CLINICAL TRIAL
    Ramirez-Bosca, A.
    Zapater Hernandez, P.
    Betlloch, I
    Albero, F.
    Martinez, A.
    De la Parte, Horga J. F.
    Diaz Alperi, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 28 - 28
  • [7] Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis
    Gonzales, Andrea J.
    Aleo, Michelle
    Mahabir, Sean
    Messamore, James
    Stegemann, Michael
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2024, 47 (06) : 447 - 453
  • [8] Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial
    Yang, Hyeon-Jong
    Min, Taek Ki
    Lee, Hae Won
    Pyun, Bok Yang
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2014, 6 (03) : 208 - 215
  • [9] Fluoxetine (SSRI) treatment of canine atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover trial
    Fujimura, M.
    Ishimaru, H.
    Nakatsuji, Y.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2014, 17 (02): : 371 - 373
  • [10] Probiotic Supplement Reduces Atopic Dermatitis in Preschool ChildrenA Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
    Sergei V. Gerasimov
    Volodymyr V. Vasjuta
    Oksana O. Myhovych
    Lyudmyla I. Bondarchuk
    American Journal of Clinical Dermatology, 2010, 11 : 351 - 361
12345